|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
WO2007070660A2
(en)
|
2005-12-13 |
2007-06-21 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
|
US9770535B2
(en)
|
2007-06-21 |
2017-09-26 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
US8563002B2
(en)
|
2007-12-24 |
2013-10-22 |
Glaxosmithkline Biologicals, S.A. |
Recombinant RSV antigens
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
CA2715460C
(en)
|
2008-02-13 |
2020-02-18 |
President And Fellows Of Harvard College |
Continuous cell programming devices
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
ES2987238T3
(es)
|
2008-12-09 |
2024-11-14 |
Novavax Inc |
Proteínas F del RSV modificadas y métodos de su uso
|
|
PL2445526T3
(pl)
*
|
2009-06-24 |
2017-08-31 |
Glaxosmithkline Biologicals S.A. |
Rekombinowane antygeny rsv
|
|
SG176807A1
(en)
*
|
2009-06-24 |
2012-01-30 |
Id Biomedical Corp Quebec |
Vaccine
|
|
EP4183412B1
(en)
|
2009-07-15 |
2024-08-14 |
GlaxoSmithKline Biologicals SA |
Rsv f protein compositions and methods for making same
|
|
EP2453903B1
(en)
*
|
2009-07-17 |
2016-08-17 |
Industry Academic Cooperation Foundation, Hallym University |
Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
|
|
AU2010278702C1
(en)
|
2009-07-31 |
2016-07-14 |
Forsyth Dental Infirmary For Children |
Programming of cells for tolerogenic therapies
|
|
US8846056B2
(en)
*
|
2009-08-04 |
2014-09-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control |
Anti-RSV immunogens and methods of immunization
|
|
CN106008716B
(zh)
|
2010-07-07 |
2019-08-13 |
人工细胞科技公司 |
呼吸道合胞病毒抗原组合物和方法
|
|
HRP20200310T1
(hr)
|
2010-10-06 |
2020-08-21 |
President And Fellows Of Harvard College |
Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
|
|
EP2668282A2
(en)
*
|
2011-01-28 |
2013-12-04 |
MedImmune, LLC |
Expression of soluble viral fusion glycoproteins in mammalian cells
|
|
JP2014518620A
(ja)
*
|
2011-04-26 |
2014-08-07 |
モレキュラー エクスプレス，インコーポレイテッド |
リポソーム製剤
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
ES2685327T3
(es)
|
2011-04-28 |
2018-10-08 |
President And Fellows Of Harvard College |
Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
|
|
RS56748B1
(sr)
|
2011-05-13 |
2018-03-30 |
Glaxosmithkline Biologicals Sa |
Pre-fuzioni rsv f antigeni
|
|
US9486512B2
(en)
|
2011-06-03 |
2016-11-08 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
US9463236B2
(en)
|
2011-08-29 |
2016-10-11 |
Tokushima University |
RSV mucosal vaccine
|
|
SG10201602434UA
(en)
*
|
2011-09-30 |
2016-05-30 |
Novavax Inc |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
WO2013155205A1
(en)
*
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
|
ES2773895T3
(es)
|
2012-04-16 |
2020-07-15 |
Harvard College |
Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
|
|
SI2879702T1
(sl)
*
|
2012-08-01 |
2020-02-28 |
Bavarian Nordic A/S |
Cepivo na osnovi rekombinantnega modificiranega virusa vakcinacije Ankara (MVA) proti respiratornemu sincitialnemu virusu (RSV)
|
|
ES2767324T3
(es)
*
|
2012-08-01 |
2020-06-17 |
Bavarian Nordic As |
Vacuna de virus vaccinia modificado de Ankara (MVA) recombinante para el virus sincicial respiratorio (VRS)
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
US20140037680A1
(en)
*
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
JP2016509015A
(ja)
*
|
2013-02-11 |
2016-03-24 |
ノババックス，インコーポレイテッド |
呼吸器合胞体ウイルス及びインフルエンザ用の混合ワクチン
|
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
|
CN107073090A
(zh)
|
2014-04-30 |
2017-08-18 |
哈佛学院董事会 |
结合的疫苗装置和杀死癌细胞的方法
|
|
EP3154576A1
(en)
|
2014-06-13 |
2017-04-19 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic combinations
|
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
US11150242B2
(en)
|
2015-04-10 |
2021-10-19 |
President And Fellows Of Harvard College |
Immune cell trapping devices and methods for making and using the same
|
|
CN114617959A
(zh)
|
2015-09-03 |
2022-06-14 |
诺瓦瓦克斯股份有限公司 |
具有改进的稳定性和免疫原性的疫苗组合物
|
|
RU2723039C2
(ru)
|
2015-12-23 |
2020-06-08 |
Пфайзер Инк. |
Мутанты белка f rsv
|
|
WO2017136837A1
(en)
|
2016-02-06 |
2017-08-10 |
President And Fellows Of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
|
AU2017295704B2
(en)
|
2016-07-13 |
2023-07-13 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
CN110418651A
(zh)
|
2016-08-02 |
2019-11-05 |
哈佛学院院长等 |
用于调节免疫应答的生物材料
|
|
IL264464B2
(en)
|
2016-08-03 |
2024-02-01 |
Lonza Walkersville Inc |
A method for detecting endotoxin using Limulus extract of amoeba, which is mainly free of coagulogen
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
WO2018132562A1
(en)
*
|
2017-01-11 |
2018-07-19 |
Lonza Walkersville, Inc. |
Coagulogen-free clarified limulus amebocyte lysate
|
|
CN111148509A
(zh)
|
2017-07-24 |
2020-05-12 |
诺瓦瓦克斯股份有限公司 |
治疗呼吸系统疾病的方法和组合物
|
|
US20200299651A1
(en)
|
2017-10-16 |
2020-09-24 |
Glaxosmithkline Biologicals Sa |
Simian adenoviral vectors with two expression cassettes
|
|
MX394509B
(es)
|
2017-10-16 |
2025-03-12 |
Glaxosmithkline Biologicals Sa |
Promotor mejorado
|
|
US11859199B2
(en)
|
2017-10-16 |
2024-01-02 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
CN120227451A
(zh)
|
2018-03-19 |
2025-07-01 |
诺瓦瓦克斯股份有限公司 |
多价流感纳米颗粒疫苗
|
|
MX2020013553A
(es)
|
2018-06-12 |
2021-02-26 |
Glaxosmithkline Biologicals Sa |
Polinucleotidos y polipeptidos de adenovirus.
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
JP2022514568A
(ja)
|
2018-12-17 |
2022-02-14 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫系のモジュレーションのための生物工学的スキャフォールドおよびその使用
|
|
WO2020175660A1
(ja)
|
2019-02-28 |
2020-09-03 |
Ｋｍバイオロジクス株式会社 |
Ｒｓｖ ｆ／ｇキメラワクチン
|
|
JP2022549270A
(ja)
|
2019-09-23 |
2022-11-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
バイオマテリアルベースの無抗原ワクチンおよびその使用
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|
|
WO2025263563A1
(ja)
*
|
2024-06-20 |
2025-12-26 |
Ｋｍバイオロジクス株式会社 |
ＲＳＶ ＦＧキメラｍＲＮＡワクチン
|
|
WO2026148356A1
(en)
|
2025-01-06 |
2026-07-09 |
BioNTech SE |
Coronavirus and influenza immunogenic combinations
|